Epiomed Therapeutics Inc is categorized under Medical Research in Laguna Hills, CA and active since 2010.
Epiomed Therapeutics Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact David R Helton at the company’s single location by writing to 24310 Moulton Parkway O-208, Laguna Hills, California CA 92637 or by phoning (949) 981-6442. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Epiomed Therapeutics Inc |
| Contact Person: | David R Helton |
| Address: | 24310 Moulton Parkway O-208, Laguna Hills, California 92637 |
| Phone Number: | (949) 981-6442 |
| Website Address: | epiomed.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Epiomed Therapeutics Inc was started in 2010 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David R Helton for inquiries that concern Epiomed Therapeutics Inc by calling the company number (949) 981-6442, as your correspondence is most welcome. Additionally, the physical location of the single location of Epiomed Therapeutics Inc can be found at the coordinates as well as the street address 24310 Moulton Parkway O-208 in Laguna Hills, California 92637.
For its online presence, you may visit Epiomed Therapeutics Inc’s website at epiomed.com and engage with its social media outlets through on Twitter and on Facebook.